Armata Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| 45.6 | 16.3 | 39.4 | 38.6 | 69.0 | 82.5 | 138.0 | – | – | – | – | – | – | – | – | 2,308.2 | 184.5 | 67.2 | 52.0 | 32.7 | 22.4 | 32.3 | 30.6 | 26.2 | 27.8 | 7.9 | 12.1 | 9.5 | 26.7 | 25.5 | 32.3 | 43.9 | 15.9 | 21.7 | 11.6 | 10.0 | 21.5 | 46.7 | 71.6 | 72.8 | |
| 0.9 | 0.4 | 1.1 | 0.4 | 0.8 | 1.2 | 1.3 | 0.6 | 0.7 | 0.1 | 0.3 | 1.4 | 1.9 | 2.2 | 1.0 | 2.4 | 2.4 | 2.9 | 2.9 | 3.5 | 3.8 | 5.7 | 2.3 | 2.6 | 3.3 | 1.2 | 2.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.5 | 30.7 | -38.7 | 5.6 | – | – | – | – | – | – | – | – | – | – | 1,706.1 | 141.4 | 58.2 | 41.3 | 27.7 | 19.8 | 30.4 | 20.9 | 19.6 | 23.5 | 8.2 | 16.1 | 7.0 | 41.9 | 42.8 | 53.9 | 68.5 | 33.3 | 39.0 | 31.9 | 26.4 | 48.4 | 98.2 | 137.5 | 112.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 11.1 | – | – | – | – | – | |
| -70.4% | -256.0% | -152.2% | -260.9% | -103.5% | -97.4% | -64.8% | -171.0% | -201.6% | -964.7% | -610.2% | -39.6% | -43.8% | -50.0% | -54.1% | -22.0% | -25.8% | -34.5% | -20.9% | -21.3% | -25.4% | -17.2% | -16.1% | -19.5% | -22.1% | -80.2% | -82.4% | -137.2% | -51.7% | -48.9% | -31.5% | -28.3% | -48.5% | -35.1% | -66.8% | -46.7% | -25.2% | -11.5% | -6.6% | -6.4% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | -749.3% | -515.4% | -405.9% | -347.4% | -410.2% | -412.9% | -455.7% | -535.7% | -622.0% | -566.8% | -383.6% | -127.8% | 78.1% | 69.2% | 77.4% | 74.4% | 70.5% | 79.1% | 70.5% | 68.8% | 69.0% | 66.9% | |
| -3,949.2% | -5,319.6% | -6,924.6% | -17,378.7% | -13,767.5% | -14,048.7% | -14,954.7% | – | – | – | – | – | – | – | – | -64,519.4% | -5,908.2% | -2,623.0% | -1,170.0% | -783.4% | -607.3% | -532.5% | -584.9% | -563.3% | -599.8% | -670.8% | -779.7% | -958.6% | -1,027.6% | -902.8% | -846.4% | -1,130.9% | -758.7% | -820.2% | -859.8% | -514.4% | -659.9% | -747.0% | -715.6% | -734.2% | |
| -3,160.9% | -7,245.4% | -10,367.2% | -19,983.3% | -17,082.1% | -11,163.5% | -12,005.7% | – | – | – | – | – | – | – | – | -68,803.2% | -6,314.4% | -2,695.1% | -1,196.3% | -795.8% | -594.9% | -517.5% | -569.2% | -549.6% | -599.5% | -670.2% | -841.2% | -887.5% | -1,468.7% | -1,524.5% | -1,693.5% | -1,802.7% | -756.6% | -365.6% | -9.1% | -374.3% | -928.0% | -3,544.0% | -5,432.8% | -3,467.0% | |
| -3,207.9% | -4,180.0% | -5,997.3% | -10,084.3% | -7,142.7% | -8,043.5% | -8,945.3% | – | – | – | – | – | – | – | – | -50,700.0% | -4,757.4% | -2,320.0% | -1,086.9% | -698.5% | -569.6% | -556.1% | -492.2% | -511.4% | -614.9% | -629.8% | -996.9% | -1,307.0% | -1,382.2% | -1,247.2% | -1,015.9% | -1,239.1% | -769.8% | -762.1% | -772.0% | -467.3% | -542.7% | -536.4% | -470.4% | -465.3% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -63.5% | -193.7% | -285.4% | -218.9% | -204.8% | -166.1% | -112.7% | -111.7% | -148.0% | -142.9% | -253.8% | -60.7% | -105.3% | -132.6% | -62.2% | -72.0% | -81.8% | -117.6% | -66.4% | -84.1% | -99.9% | -91.2% | -43.0% | -55.3% | -71.6% | -102.3% | -189.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -44.4% | -103.5% | -132.7% | -142.9% | -145.0% | -115.3% | -88.4% | -79.5% | -95.5% | -101.9% | -130.9% | -39.4% | -65.1% | -76.1% | -47.2% | -43.1% | -44.1% | -56.1% | -42.8% | -49.9% | -55.6% | -33.2% | -24.5% | -29.2% | -35.2% | -38.5% | -39.2% | -32.8% | -52.8% | -70.2% | -66.1% | -61.9% | -42.1% | -21.9% | -0.5% | -31.8% | -52.4% | -226.1% | -404.9% | -213.6% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | -4.9 | -1.6 | -8.4 | -7.4 | – | – | – | – | – | -1.8 | -12 | -7.4 | -4.7 | -23 | -19 | -14 | -7.4 | -20 | -15 | -10 | -8.8 | -45 | -35 | -23 | 2.2 | 20 | -11 | 62 | 78 | 102 | 92 | 95 | 90 | 96 | 112 | 136 | 253 | 343 | 222 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.1 | – | – | – | – | – | |
| 70.0% | 53.4% | 46.5% | 65.3% | 70.8% | 69.4% | 78.4% | 71.2% | 64.5% | 71.3% | 51.6% | 64.8% | 61.9% | 57.3% | 75.9% | 59.9% | 53.9% | 47.7% | 64.4% | 59.3% | 55.7% | 36.4% | 57.1% | 52.8% | 49.1% | 37.6% | 20.6% | -11.0% | -11.0% | -32.6% | -47.0% | -42.6% | -51.9% | -55.6% | -61.6% | -86.0% | -106.8% | -284.3% | -446.4% | -257.0% | |
| – | 0.1 | 0.1 | 0.1 | 0.0 | – | – | – | – | – | 0.7 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.5 | 2.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -145.65 | -273.33 | -158.34 | -56.47 | -31.53 | -18.93 | -13.40 | -28.03 | -30.52 | -36.44 | -37.89 | -1.78 | -2.00 | -2.02 | -1.99 | -1.16 | -1.10 | -1.20 | -1.10 | -0.97 | -0.96 | -0.88 | -0.91 | -0.82 | -0.91 | -1.02 | -1.18 | -1.02 | -1.65 | -1.91 | -2.20 | -1.15 | -1.14 | -0.32 | -0.01 | -0.71 | -1.29 | -4.78 | -7.74 | -3.10 | |
| 4.61 | 3.77 | 1.53 | 0.28 | 0.18 | 0.17 | 0.11 | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.02 | 0.04 | 0.09 | 0.12 | 0.16 | 0.17 | 0.16 | 0.15 | 0.15 | 0.15 | 0.14 | 0.12 | 0.11 | 0.13 | 0.13 | 0.06 | 0.15 | 0.09 | 0.13 | 0.19 | 0.14 | 0.13 | 0.14 | 0.09 | |
| 229.48 | 141.08 | 55.48 | 25.80 | 15.39 | 11.40 | 11.89 | 25.09 | 20.62 | 25.50 | 14.93 | 2.93 | 1.90 | 1.52 | 3.20 | 1.62 | 1.34 | 1.02 | 1.66 | 1.16 | 0.96 | 0.97 | 2.12 | 1.48 | 1.26 | 1.00 | 0.62 | -0.34 | -0.34 | -0.89 | -1.56 | -0.79 | -1.41 | -0.81 | -1.49 | -1.92 | -2.64 | -6.01 | -8.53 | -3.73 | |
| -147.81 | -157.69 | -91.59 | -28.49 | -13.18 | -13.64 | -9.98 | -26.34 | -28.23 | -28.36 | -25.63 | -1.59 | -1.62 | -1.65 | -1.68 | -0.86 | -0.83 | -1.04 | -1.00 | -0.85 | -0.92 | -0.95 | -0.79 | -0.76 | -0.93 | -0.96 | -1.40 | -1.51 | -1.55 | -1.56 | -1.32 | -0.79 | -1.16 | -0.67 | -1.00 | -0.89 | -0.76 | -0.72 | -0.67 | -0.42 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.